Sensus Healthcare Inc. logo

SRTS

NASDAQ

Sensus Healthcare Inc.

Website

Sensus Healthcare Inc. (SRTS) is a Medical/Dental Instruments company listed on NASDAQ. In the last 30 days Quantisnow tracked 5 wire items for SRTS, including 2 earnings updates, 2 SEC filings and 1 press release or news item. The most recent was published Nov 13, 2026.

Sensus Healthcare, Inc. manufactures, distributes, and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sculptura product, a proprietary modulated robotic brachytherapy oncology therapy system that uses patented Beam Sculpting capabilities to treat various cancers during surgery; and Sentinel service program, which offers its customers protection for their systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

SRTS rankings

Financial highlights

Full financials
Revenue, TTM
$16.62M
Revenue growth
-53.3%
Net income, TTM
-$16.04M
Net margin
-96.5%
Free cash flow, TTM
-$11.53M
Cash
$12.92M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

News · 26 weeks16+100%
2026-05-24: 02026-05-31: 22026-06-07: 02026-06-14: 02026-06-21: 02026-06-28: 02026-07-05: 02026-07-12: 02026-07-19: 02026-07-26: 12026-08-02: 02026-08-09: 32026-08-16: 02026-08-23: 42026-08-30: 12026-09-06: 02026-09-13: 02026-09-20: 02026-09-27: 02026-10-04: 02026-10-11: 02026-10-18: 02026-10-25: 12026-11-01: 02026-11-08: 42026-11-15: 0
2026-05-242026-11-15
Mix1090d
  • Insider5(50%)
  • Earnings2(20%)
  • SEC Filings2(20%)
  • Other1(10%)
Activity · 52 weeks4834 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

SRTS FAQ

11 questions
  • What does Sensus Healthcare Inc. do?
    Sensus Healthcare, Inc. manufactures, distributes, and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides...
  • What is the latest news on SRTS?
    In the last 30 days Quantisnow tracked 5 wire items for SRTS: 2 earnings updates, 2 SEC filings and 1 press release or news item. The most recent was published on November 13, 2026.
  • What is SRTS revenue?
    Sensus Healthcare Inc. (SRTS) reported $16.62M of revenue for the twelve months ended Sep 30, 2026. That is down 53.3% from the year before. Revenue for fiscal 2025 was $27.48M.
  • Is SRTS profitable?
    No. Sensus Healthcare Inc. reported a net loss of $16.04M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does SRTS have?
    Sensus Healthcare Inc. reported $12.92M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does SRTS stock trade?
    Sensus Healthcare Inc. (SRTS) is listed on NASDAQ.
  • What sector and industry is SRTS in?
    Sensus Healthcare Inc. operates in the Health Care sector, Medical/Dental Instruments industry.
  • When did Sensus Healthcare Inc. go public?
    Sensus Healthcare Inc. (SRTS) completed its IPO in 2016.
  • What are analysts saying about SRTS?
    Sensus Healthcare Inc. has had 8 recent analyst actions on file. The most recent action was from Alliance Global Partners: Buy with a $7.50 price target on 2026-03-06. Recent price targets range from $7.00 to $18.00.
  • What companies are similar to SRTS?
    Notable peers in the same industry include ARAY (Accuray Incorporated). Compare SRTS side-by-side with any of them on Quantisnow.
  • How can I track SRTS on Quantisnow?
    Quantisnow aggregates Sensus Healthcare Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SRTS to receive live email and push alerts on every new disclosure.